A groundbreaking pilot program in Utah employs AI to autonomously renew prescriptions for chronic conditions like hypertension and diabetes. However, a paper co-authored by legal expert Sara Gerke highlights significant clinical and legal concerns, particularly regarding the role of the FDA and the necessity of human oversight in prescribing. Though the initiative aims to enhance medication adherence, it may violate existing laws, as AI lacks FDA approval and requires a licensed human clinician for prescription refills. Gerke warns that without proper regulation, this expanding use of AI in healthcare could compromise patient safety.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.miragenews.com/ai-driven-drug-prescriptions-face-potential-1664452/
